Acquirer | Target | Price |
---|---|---|
Biotechnology | ||
Allergan plc | Naurex Inc. | $560 million |
Pharmaceuticals | ||
Teva Pharmacutical Industries Limited | Allergan Generics | $40.5 billion |
Hikma Pharmaceuticals PLC | Roxane Laboratories, Inc. | $2.65 billion |
Sanofi | Collaboration with Regeneron | $640 million |
Source: Health Care M&A News, July 31, 2015 |